The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,201–3,300 of 31,469
Ärnlöv, J., Zethelius, B., Risérus, U., Basu, S., Berne, C., Vessby, B., Alfthan, G., & Helmersson, J. (2008) · Diabetologia · doi:10.1007/s00125-008-1189-3 · Cited by 99
Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system
Francini, F., Castro, M. C., Schinella, G. R., García, M. E., Maiztegui, B., Raschia, M. A., Gagliardino, J. J., & Massa, M. L. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.05.005 · Cited by 99
Johansson‐Persson, A., Ulmius, M., Cloetens, L., Karhu, T., Herzig, K., & Önning, G. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0496-8 · Cited by 102
Circulating Oxidized LDL and Inflammation in Extreme Pediatric Obesity
Norris, A. L., Steinberger, J., Steffen, L. M., Metzig, A. M., Schwarzenberg, S. J., & Kelly, A. S. (2011) · Obesity · doi:10.1038/oby.2011.21 · Cited by 99
Lima, M. D. L., Cruz, T., Rodrigues, L. E. A., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.019 · Cited by 99
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
Goodarzi, M. O., Erickson, S. W., Port, S. C., Jennrich, R. I., & Korenman, S. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1006 · Cited by 99
Rask‐Madsen, C., Ihlemann, N., Krarup, T., Christiansen, E., Køber, L., Kistorp, C. N., & Torp-Pedersen, C. T. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2611 · Cited by 106
Tomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0193-8 · Cited by 99
Senaphan, K., Kukongviriyapan, U., Sangartit, W., Pakdeechote, P., Pannangpetch, P., Prachaney, P., Greenwald, S. E., & Kukongviriyapan, V. (2015) · Nutrients · doi:10.3390/nu7085283 · Cited by 99
Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients
Xu, J. Y., Dan, Q. H., Chan, V., Wat, N. M. S., Tam, S., Tiu, S. C., Lee, K. F., Siu, S. C., Tsang, M. W., Fung, L. M., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201347 · Cited by 100
Chromium Treatment Has No Effect in Patients With Type 2 Diabetes in a Western Population
Kleefstra, N., Houweling, S. T., Bakker, S. J. L., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2192 · Cited by 99
Circulating procoagulant microparticles in obesity
Goichot, B., Grunebaum, L., Desprez, D., Vinzio, S., Meyer, L., Schlienger, J.-L., Lessard, M., & Simon, C. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70251-3 · Cited by 99
Racial Differences in Natriuretic Peptide Levels
Gupta, D. K., de Lemos, J. A., Ayers, C. R., Berry, J. D., & Wang, T. J. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.02.008 · Cited by 100
Polycystic ovaries, obesity and insulin resistance in women with epilepsy
Luef, G. J., Abraham, I., Haslinger, M., Trinka, E., Seppi, K., Unterberger, I., Alge, A., Windisch, J., Lechleitner, M., & Bauer, G. J. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0731-3 · Cited by 99
Elkind-Hirsch, K. E., Chappell, N., Seidemann, E., Storment, J., & Bellanger, D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab408 · Cited by 96
Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., & Esmaillzadeh, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3313-x · Cited by 98
Tomeno, W., Kawashima, K., Yoneda, M., Saito, S., Ogawa, Y., Honda, Y., Kessoku, T., Imajo, K., Mawatari, H., Fujita, K., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12897 · Cited by 98
Zhang, W., Xu, Y.-Z., Liu, B., Wu, R., Yang, Y., Xiao, X., & Zhang, X. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/603409 · Cited by 98
Lalanza, J. F., Caimari, A., Bas-Prior, J. M. D., Torregrosa, D., Cigarroa, I., Pallàs, M., Capdevila, L., Arola, L., & Escorihuela, R. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085049 · Cited by 98
Longenecker, C. T., Hileman, C. O., Carman, T. L., Ross, A. C., Seydafkan, S., Brown, T. T., Labbato, D. E., Storer, N. J., Tangpricha, V., & McComsey, G. A. (2011) · Antiviral Therapy · doi:10.3851/imp1983 · Cited by 98
Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity
Schultz, A., Neil, D., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121873 · Cited by 99
High prevalence of glucose metabolism disturbance in patients with lichen planus
Seyhan, M., Özcan, H., Şahin, İ., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.016 · Cited by 98
Serum Uric Acid and Blood Pressure in Children at Cardiovascular Risk
Viazzi, F. C., Antolini, L., Giussani, M., Brambilla, P., Galbiati, S., Mastriani, S., Stella, A., Pontremoli, R., Valsecchi, M. G., & Genovesi, S. (2013) · PEDIATRICS · doi:10.1542/peds.2013-0047 · Cited by 98
Martin, R. M., Ben‐Shlomo, Y., Gunnell, D., Elwood, P., Yarnell, J. W. G., & Smith, G. D. (2005) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2003.018952 · Cited by 98
Adiponectin and Risk of Coronary Heart Disease in Older Men and Women
Kizer, J. R., Barzilay, J. I., Kuller, L. H., & Gottdiener, J. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0640 · Cited by 96
Stote, K. S., Clevidence, B. A., Novotny, J. A., Henderson, T. R., Radecki, S. V., & Baer, D. J. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.101 · Cited by 98
Bedtime Variability and Metabolic Health in Midlife Women: The SWAN Sleep Study
Taylor, B. J., Matthews, K. A., Hasler, B. P., Roecklein, K. A., Kline, C. E., Buysse, D. J., Kravitz, H. M., Tiani, A. G., Harlow, S. D., & Hall, M. H. (2016) · SLEEP · doi:10.5665/sleep.5464 · Cited by 98
Garcovich, M., Veraldi, S., Stasio, E. D., et al. (2016) · Radiology · doi:10.1148/radiol.2016161002 · Cited by 98
Pembroke, T., Deschênes, M., Lebouché, B., Benmassaoud, A., Sewitch, M. J., Ghali, P., Wong, P. Y. N., Halme, A. S., Vuille‐Lessard, É., Pexos, C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.011 · Cited by 101
Stavnsbo, M., Resaland, G. K., Anderssen, S., Steene-Johannessen, J., Domazet, S. L., Skrede, T., Sardinha, L., Kriemler, S., Ekelund, U., Andersen, L., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.10.003 · Cited by 95
Parcha, V., Heindl, B. F., Kalra, R., Li, P., Gower, B. A., Arora, G., & Arora, P. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab645 · Cited by 108
Trends in the Prevalence of Metabolically Healthy Obesity Among US Adults, 1999-2018
Wang, J., Xia, P., Ma, M., Li, Y., Geng, T., Zhang, Y., Tu, Z., Jiang, L., Zhou, L., Zhang, B.-F., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.2145 · Cited by 109
Raff, M., Tholstrup, T., Basu, S., Nonboe, P., Sørensen, M. T., & Straarup, E. M. (2008) · Journal of Nutrition · doi:10.1093/jn/138.3.509 · Cited by 98
Taylor, C. G., Noto, A. D., Defries, D. M., Froese, S., & Malcolmson, L. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719819 · Cited by 99
The FTO Obesity Gene. Genotyping and Gene Expression Analysis in Morbidly Obese Patients
Aben, K. K. H., González‐Sánchez, J. L., Martínez-Larrad, M. T., García, A. J. T., Fernández‐Represa, J. A., Anchuelo, A. C., Pérez‐Barba, M., & Serrano‐Ríos, M. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9727-0 · Cited by 99
Moreno‐Navarrete, J. M., Manco, M., Ibáñez, J., García‐Fuentes, E., Ortega, F. J., Gorostiaga, E. M., Vendrell, J. J., Izquierdo, M., Martínez, C., Nolfe, G., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.242 · Cited by 100
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease
Elias, M. C., Parise, E. R., de Carvalho, L., Szejnfeld, D., & Netto, J. P. (2009) · Nutrition · doi:10.1016/j.nut.2009.09.001 · Cited by 98
Lim, S. K., Bae, J. H., Chun, E. J., Kim, H., Kim, S. Y., Kim, K. M., Choi, S. H., Park, K. S., Florez, J. C., & Jang, H. C. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0581-3 · Cited by 99
Inhibitory effects of sweet cherry anthocyanins on the obesity development in C57BL/6 mice
Wu, T., Tang, Q., Yu, Z., Gao, Z., Hu, H., Chen, W., Zheng, X., & Yu, T. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.854749 · Cited by 100
Diamant, M., Lamb, H. J., van de Ree, M. A., Endert, E. L., Groeneveld, Y., Bots, M. L., Kostense, P. J., & Radder, J. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1579 · Cited by 98
Sheu, W. H., Chen, Y., Lee, W., Wang, C., & Lin, L. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01729.x · Cited by 99
Kraemer‐Aguiar, L. G., Laflôr, C. M., & Bouskela, E. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.034 · Cited by 98
Okita, K., Iwahashi, H., Kozawa, J., Okauchi, Y., Funahashi, T., Imagawa, A., & Shimomura, I. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0320 · Cited by 98
Wilkin, T. J., & Murphy, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803317 · Cited by 97
Ben, M. D., Polimeni, L., Carnevale, R., Bartimoccia, S., Nocella, C., Baratta, F., Loffredo, L., Pignatelli, P., Violi, F., & Angelico, F. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-81 · Cited by 97
Alkerwi, A., Shivappa, N., Crichton, G. E., & Hébert, J. R. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.07.017 · Cited by 99
Stolarczyk, É., Vong, C. T., Perucha, E., Jackson, I., Cawthorne, M. A., Wargent, E. T., Powell, N., Canavan, J. B., Lord, G. M., & Howard, J. K. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.019 · Cited by 98
Methylglyoxal, Cognitive Function and Cerebral Atrophy in Older People
Srikanth, V. K., Westcott, B., Forbes, J. M., Phan, T. G., Beare, R. J., Venn, A., Pearson, S., Greenaway, T. M., Parameswaran, V., & Münch, G. W. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls100 · Cited by 98
van Meijl, L. E. C., & Mensink, R. P. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.008 · Cited by 99
Kizer, J. R., Benkeser, D. C., Arnold, A. M., Mukamal, K. J., Ix, J. H., Zieman, S. J., Siscovick, D. S., Tracy, R. P., Mantzoros, C. S., deFilippi, C. R., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.135202 · Cited by 98
Chang, Y., Chang, T., Lee, W., & Chuang, L. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.011 · Cited by 98
TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population
Cauchi, S., Meyre, D., Choquet, H., Christian Dina, C., Born, C., Marre, M., Balkau, B., Froguel, P., & for the DESIR Study Group (2006) · Diabetes · doi:10.2337/db06-0692 · Cited by 98
Parretti, E., Lapolla, A., Dalfrà, M., Pacini, G., Mari, A., Cioni, R. M., Marzari, C., Scarselli, G., & Mello, G. (2006) · Hypertension · doi:10.1161/01.hyp.0000205122.47333.7f · Cited by 97
Dysregulation of Placental Endothelial Lipase in Obese Women With Gestational Diabetes Mellitus
Gauster, M., Hiden, U., van Poppel, M. N. M., Frank, S., Wadsack, C., Mouzon, S. H., & Desoyé, G. (2011) · Diabetes · doi:10.2337/db10-1434 · Cited by 96
Verma, M., Paneri, S., Badi, P., & Raman, P. (2006) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02913083 · Cited by 98
Rizzo, M., Berneis, K. K., Hersberger, M., Pepe, I., Fede, G. D., Rini, G. B., Spinas, G. A., & Carmina, E. (2009) · Human Reproduction · doi:10.1093/humrep/dep121 · Cited by 97
Zhang, Y., Wat, N. M. S., STRATTON, I. M., Warren-Perry, M., Orho, M., Groop, L., & Turner, R. C. (1996) · Diabetologia · doi:10.1007/s001250050605 · Cited by 96
Self-citationTNF- and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study
Escobar-Morreale, H. F., Calvo, R. M., Sancho, J., & Millán, J. L. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7770 · Cited by 104
Lien, L. F., Haqq, A. M., Arlotto, M., Slentz, C. A., Muehlbauer, M. J., McMahon, R. L., Rochon, J., Gallup, D., Bain, J. R., Ilkayeva, O., et al. (2009) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2008.0035 · Cited by 97
Morning Hyperglycemic Excursions
Monnier, L., Colette, C., Rabasa-Lhoret, R., Lapinski, H., Caubel, C., Avignon, A., & Boniface, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.737 · Cited by 96
Fat Oxidation before and after a High Fat Load in the Obese Insulin-Resistant State
Blaak, E. E., Hul, G., Verdich, C., Stich, V., Martinez, A., Petersen, M., Feskens, E. F. M., Patel, K., Oppert, J. M., Barbe, P., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1598 · Cited by 97
Nestel, P. J., Straznicky, N. E., Mellett, N. A., Wong, G., Souza, D. P. D., Tull, D., Barlow, C. K., Grima, M. T., & Meikle, P. J. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.071712 · Cited by 98
Zhao, W., Gong, W., Wu, N., Li, Y., Ye, K., Lü, B., Zhang, Z., Qu, S., Li, Y., Yang, Y., et al. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-37 · Cited by 97
Lee, E. Y., Kim, H. M., Kang, J. S., Lee, E. Y., Yadav, D., Kwon, M.-H., Kim, Y. M., Kim, H. S., & Chung, C. H. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv377 · Cited by 97
Chen, X., Talati, M. H., Fessel, J. P., Hemnes, A. R., Gladson, S., French, J. L., Shay, S. D., Trammell, A. W., Phillips, J. A., Hamid, R., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016133 · Cited by 92
Petta, S., Marco, V. D., Pipitone, R. M., Grimaudo, S., Buscemi, C., Craxı̀, A., & Buscemi, S. (2018) · Liver International · doi:10.1111/liv.13743 · Cited by 98
Yu, E., Papandreou, C., Ruiz‐Canela, M., Guasch‐Ferré, M., Clish, C. B., Dennis, C., Liang, L., Corella, D., Fitó, M., Razquín, C., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.288720 · Cited by 98
Youssef, D. A., El‐Fayoumi, H. M., & Mahmoud, M. F. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.010 · Cited by 97
Huang, R., Lillycrop, K. A., Beilin, L. J., Godfrey, K. M., Anderson, D. R., Mori, T. A., Rauschert, S., Craig, J. M., Oddy, W. H., Ayonrinde, O. T., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02076 · Cited by 99
Luukkonen, P. K., Porthan, K., Ahlholm, N., Rosqvist, F., Dufour, S., Zhang, X., Lehtimäki, T. E., Seppänen, W., Orho‐Melander, M., Hodson, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.008 · Cited by 97
The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance
Baneu, P., Văcărescu, C., Dragan, S. R., Cirin, L., Lazăr-Höcher, A.-I., Cozgarea, A., Faur-Grigori, A. A., Crișan, S., Gaiță, D. I., Luca, C. T., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071493 · Cited by 116
O’Neil, C. E., Fulgoni, V. L. I., & Nicklas, T. A. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0052-x · Cited by 100
Paolisso, G., Manzella, D., Montano, N., Gambardella, A., & Varricchio, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6511 · Cited by 96
Diabetes, Insulin Resistance, and Dementia Among HIV-1-Infected Patients
Valcour, V., Shikuma, C. M., Shiramizu, B. T., Williams, A. E., Watters, M. R., Poff, P., Grove, J., Selnes, O. A., & Sacktor, N. C. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00006 · Cited by 97
Reddigan, J. I., Ardern, C. I., Riddell, M. C., & Kuk, J. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.005 · Cited by 102
Adiponectin and its receptors in patients with chronic hepatitis C
Jonsson, J. R., Moschen, A. R., Hickman, I. J., Richardson, M. M., Kaser, S., Clouston, A. D., Powell, E. E., & Tilg, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.030 · Cited by 97
Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers
García‐Díaz, D. F., Campión, J., Milagro, F. I., & Martínez, J. A. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9531-5 · Cited by 97
Bahijri, S., Borai, A., Ajabnoor, G., Abdulkhaliq, A. A., AlQassas, I., Alshehri, D., & Chrousos, G. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060917 · Cited by 100
Shlay, J. C., Bartsch, G. E., Peng, G., Wang, J., Grünfeld, C., Gibert, C. L., Visnegarwala, F., Raghavan, S. S., Xiang, Y., Farrough, M., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31804216cf · Cited by 98
Chan, D. C., Watts, G. F., Ng, T. W., Uchida, Y., Sakai, N., Yamashita, S., & Barrett, P. H. R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045120 · Cited by 97
Sakurai, M., Nakamura, K., Miura, K., Takamura, T., Yoshita, K., Nagasawa, S., Morikawa, Y., Ishizaki, M., Kido, T., Naruse, Y., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0523-9 · Cited by 104
Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones
Laughlin, G. A., Barrett-Connor, E. L., & May, S. J. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803427 · Cited by 96
Parim, B., Nemani, H., Meriga, B., Mehar, S. K., Potana, S., & Ramgopalrao, S. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.07.008 · Cited by 101
Effect of metformin on patients with impaired glucose tolerance
Li, C. L., Pan, C., Lu, J., Zhu, Y., Wang, J. H., Deng, X., Xia, F., Wang, H. Z., & Wang, H. Y. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00090.x · Cited by 98
Kimm, H., Lee, S. W., Lee, H. S., Shim, K. W., Cho, C. Y., Yun, J. E., & Jee, S. H. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0571 · Cited by 97
Hermsdorff, H. H. M., Barbosa, K. B. F., Volp, A. C. P., Puchau, B., Bressan, J., Zulet, M. Á., & Martínez, J. A. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004235 · Cited by 97
Wasko, M. C., Kay, J., Hsia, E. C., & Rahman, M. U. (2010) · Arthritis Care & Research · doi:10.1002/acr.20414 · Cited by 98
Santos, J. L., Pérez‐Bravo, F., Carrasco, E., et al. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00551-7 · Cited by 97
Persson, M., Nilsson, J., Nelson, J. J., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.016 · Cited by 97
Models for Predicting Type 1 Diabetes in Siblings of Affected Children
Mrena, S., Virtanen, S. M., Laippala, P., Kulmala, P., Hannila, M., Åkerblom, H. K., Knip, M., & the Childhood Diabetes in Finland Study Group (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-0774 · Cited by 98
Boer, P., Meeus, M., Terblanche, E., Rombaut, L., Wandele, I. D., Hermans, L., Gysel, T., Ruige, J. B., & Calders, P. (2013) · Clinical Rehabilitation · doi:10.1177/0269215513498609 · Cited by 107
Alam, S., Stolinski, M., Pentecost, C., Boroujerdi, M. A., Jones, R. H., Sönksen, P. H., & Umpleby, A. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031036 · Cited by 98
Playford, D. A., Watts, G. F., Croft, K. D., & Burke, V. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00417-3 · Cited by 97
Nishio, K., Sakurai, M., Kusuyama, T., Shigemitsu, M., Fukui, T., Kawamura, K., Itoh, S., Konno, N., & Katagiri, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1170 · Cited by 97
Effect of Etanercept on Insulin Sensitivity in Nine Patients with Psoriasis
Marra, M., Campanati, A., Testa, R., Sirolla, C., Bonfigli, A. R., Franceschi, C., Marchegiani, F., & Offidani, A. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000408 · Cited by 98
The prevalence of polycystic ovaries in women with a history of gestational diabetes
Κousta, E., Cela, E., Lawrence, N. J., Penny, A., Millauer, B. A., White, D., Wilson, H., Robinson, S., Johnston, D. G., McCarthy, M. I., et al. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01123.x · Cited by 97
Riches, F. M., Watts, G. F., Hua, J., Stewart, G. R., Naoumova, R. P., & Barrett, P. H. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5925 · Cited by 102
Increased Risk of Type 2 Diabetes in Elderly Twins
Poulsen, P., Grunnet, L. G., Pilgaard, K., Storgaard, H., Alibegovic, A., Sonne, M. P., Carstensen, B., Beck-Nielsen, H., & Vaag, A. (2009) · Diabetes · doi:10.2337/db08-1714 · Cited by 91
Gali Ramamoorthy, T., Allen, T.-J., Davies, A., Harno, E., Sefton, C., Murgatroyd, C., & White, A. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0094-1 · Cited by 97
“serum insulin concentration (μU/ml) multiplied by fasting blood glucose levels (mg/dl) divided by 405 [32].”
MethodGunderson, E. P., Quesenberry, C. P., Jacobs, D. R., Feng, J., Lewis, C. E., & Sidney, S. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq267 · Cited by 96
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
